Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-24-003751
Filing Date
2024-01-25
Accepted
2024-01-25 16:59:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 us7291391057_012524.txt SC 13G 11816
  Complete submission text file 0001086364-24-003751.txt   13622
Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91525 | Film No.: 24562979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)